1月15日,亚盛医药在JPM大会上全面展示了公司2025年在产品商业化、全球临床开发、创新管线拓展及资本市场的里程碑进展,并对2026年的发展进行了展望。“2025年是亚盛医药全球化布局提速的关键一年,我们在产品商业化、全球临床开发、管线创新、资本市场等多维度均实现跨越式突破。从已上市的核心产品到进入后期的实体瘤项目,再到基于前沿蛋白降解技术的早期创新疗法,公司已建立起一个覆盖血液肿瘤与实体瘤、...
Source Link1月15日,亚盛医药在JPM大会上全面展示了公司2025年在产品商业化、全球临床开发、创新管线拓展及资本市场的里程碑进展,并对2026年的发展进行了展望。“2025年是亚盛医药全球化布局提速的关键一年,我们在产品商业化、全球临床开发、管线创新、资本市场等多维度均实现跨越式突破。从已上市的核心产品到进入后期的实体瘤项目,再到基于前沿蛋白降解技术的早期创新疗法,公司已建立起一个覆盖血液肿瘤与实体瘤、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.